2011 | Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir. | HEPATOLOGY |
2013 | Quasispecies and Pre-Existing Drug-Resistant Mutations of Hepatitis B Virus in Patients with Chronic Hepatitis B
| GUT AND LIVER |
2016 | Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis
| PLOS ONE |
2015 | Radioembolization With Yttrium-90 Resin Microspheres in Hepatocellular Carcinoma: A Multicenter Prospective Study | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
2012 | Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2019 | Radiomics on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Prediction of Postoperative Early and Late Recurrence of Single Hepatocellular Carcinoma
| CLINICAL CANCER RESEARCH |
2018 | Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2016 | Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data
| CANCER RESEARCH AND TREATMENT |
2016 | Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B | LIVER INTERNATIONAL |
2019 | Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
| PLOS ONE |
2015 | Relationship between Cerebral Microbleeds and Liver Stiffness Determined by Transient Elastography
| PLOS ONE |
2018 | Reply to "Radiologic Evaluation of Intrahepatic Cholangiocarcinoma Perineural Invasion" | AMERICAN JOURNAL OF ROENTGENOLOGY |
2018 | Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib | LIVER INTERNATIONAL |
2009 | Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir | ANTIVIRAL THERAPY |
2019 | Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma | RADIOTHERAPY AND ONCOLOGY |
2020 | Retrospective comparison of EASL 2018 and LI-RADS 2018 for the noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging | HEPATOLOGY INTERNATIONAL |
2021 | Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2021 | Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance
| CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
2014 | Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test. | HEPATOLOGY |
2012 | Risk assessment of development of hepatic decompensation in histologically proven hepatitis B viral cirrhosis using liver stiffness measurement. | DIGESTION |
2011 | Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model. | AMERICAN JOURNAL OF GASTROENTEROLOGY |
2011 | Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). | HEPATOLOGY |
2021 | Risk assessment of hepatocellular carcinoma and liver-related events using ultrasonography and transient elastography in patients with chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
2019 | Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
2014 | Risk Assessment of Liver-related Events Using Transient Elastography in Patients With Chronic Hepatitis B Receiving Entecavir | JOURNAL OF CLINICAL GASTROENTEROLOGY |
2011 | Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. | LANCET ONCOLOGY |
2016 | Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model | LIVER INTERNATIONAL |
2021 | Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease
| JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE |
2009 | Role of serum prothrombin induced by vitamin K absence or antagonist-II in the early detection of hepatocellular carcinoma in patients with chronic hepatitis B virus infection | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY |
2013 | Role of splenectomy in patients with hepatocellular carcinoma and hypersplenism | ANZ JOURNAL OF SURGERY |
2007 | Role of(18)F-Fluorodeoxyglucose positron Emission Tomography in detecting Extrahepatic Metastasisin pretreatment staging of hin pretreatment staging of hepatocellular carcinoma | ONCOLOGY |
2018 | Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study | CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY |
2020 | Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2016 | Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011) | HEPATOLOGY |
2018 | Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2020 | Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus
| GUT AND LIVER |
2021 | Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2015 | Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
2013 | Serum IgA reactivity against GroEL of Streptococcus sanguinis and human heterogeneous nuclear ribonucleoprotein A2/B1 in patients with Behçet disease | BRITISH JOURNAL OF DERMATOLOGY |
2020 | Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection
| CLINICAL AND MOLECULAR HEPATOLOGY |
2014 | Silencing of hypoxia-inducible factor-1β induces anti-tumor effects in hepatoma cell lines under tumor hypoxia.
| PLOS ONE |
2024 | Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea
| GUT AND LIVER |
2016 | Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial | JOURNAL OF HEPATOLOGY |
2012 | Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: a retrospective, single-institution study. | INVESTIGATIONAL NEW DRUGS |
2023 | Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2009 | Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma. | JOURNAL OF MEDICAL VIROLOGY |
2012 | Spontaneous bacterial peritonitis in patients with hepatitis B virus-related liver cirrhosis: community-acquired versus nosocomial
| YONSEI MEDICAL JOURNAL |
2019 | Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea
| ANNALS OF SURGICAL TREATMENT AND RESEARCH |
2018 | Staging for hepatocellular carcinoma in light of tumor heterogeneity: Time to change or update? | HEPATOLOGY |
2015 | Strategies to manage hepatitis C virus infection disease burden - volume 3
| JOURNAL OF VIRAL HEPATITIS |
2017 | Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis | HEPATOLOGY INTERNATIONAL |
2016 | Subclassification of Barcelona Clinic Liver Cancer B and C hepatocellular carcinoma: A cohort study of the multicenter registry database. | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2019 | Subclinical but significant liver fibrosis in patients with ANCA-associated vasculitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2023 | Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
| DIAGNOSTICS |
2014 | Surgical Resection After Down-Staging of Locally Advanced Hepatocellular Carcinoma by Localized Concurrent Chemoradiotherapy | ANNALS OF SURGICAL ONCOLOGY |
2017 | Survival Estimates after Stopping Sorafenib in Patients with Hepatocellular Carcinoma: NEXT Score Development and Validation
| GUT AND LIVER |
2013 | Survival of Hepatocellular Carcinoma Patients May be Improved in Surveillance Interval not More Than 6 Months Compared With More Than 6 Months: A 15-Year Prospective Study | JOURNAL OF CLINICAL GASTROENTEROLOGY |
2018 | Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance | JOURNAL OF MEDICAL VIROLOGY |
2010 | Systemic therapy로 부분 반응 이상의 치료 반응을 보인 간세포암종 환장 증례 : 동일한 항암제 조합으로 치료하여 전신항암요법에서는 진행성질환 상태를, 국소적 간동맥 항암제주입요법에서는 부분관해를 보인 간세포암종 1예
| Journal of the Korean Liver Cancer Study Group (대한간암연구회지) |
2014 | Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naive chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort
| CLINICAL AND MOLECULAR HEPATOLOGY |